compound features or worsening renal and other complications after delivery.
Lastly, the difference in pathogenesis also may underlie the divergence in responses to anticomplement therapy. Two years after initial reports of its use for atypical hemolytic uremic syndrome in 2009, 3, 4 eculizumab was approved in 2011 for atypical hemolytic uremic syndrome in the United States and the European Union, based on its efficacy observed in two small single-arm trials and one retrospective review of off-label cases. In contrast, eculizumab has shown no or modest efficacy for disorders such as dermatomyositis and rheumatoid arthritis that are also associated with complement activation, 5 presumably owing to immune-mediated triggers. The case reported by Drs. Burwick and Feinberg exhibited responses to eculizumab for less than 3 weeks, and there have been no additional reports, to our knowledge, that further support the use of eculizumab for HELLP syndrome. 
Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain
In their large series of women undergoing hysterectomy for benign indications, Mowers et al 1 conclude that, ".fewer than 25% of women undergoing laparoscopic or abdominal hysterectomy for chronic pelvic pain had endometriosis at the time of surgery, as determined by a systematic review of the operative findings and pathology report."
Deposits of ectopic endometrium were not the source of chronic pelvic pain in at least 75% of women in their series. If it is not endometriosis, then what is causing this substantial morbidity among women in Michigan?
There is now persuasive evidence in every organ in the female pelvis that traumatic disruption of pelvic nerves results from difficult intrapartum episodes, physical efforts during defecation, and some medical and surgical procedures for evacuation of the uterus. 2 These three primary sources of injury to pelvic autonomic nerves result in painful clinical presentations associated with aberrant reinnervation 5-10 years later.
2 Injured pelvic nerves express new P2X3 and TRPV-1 receptors that respond to stretch and touch, respectively. 3 Increasing blood flow in the second half of the menstrual cycle may activate these receptors to cause chronic pelvic pain that we label as some forms of endometriosis, chronic pelvic pain, interstitial cystitis, irritable bowel syndrome, dysmenorrhea, vulvodynia, and others.
Rather than distinguishing between women with and without endometriosis, might there be merit in distinguishing between women with intact and injured uterosacral ligaments, because important collections of uterine and tubal nerves pass through these vulnerable supports? In Reply: Dr. Xia et al note that traumatic injury to pelvic nerves followed by aberrant reinnervation may be a cause of chronic pelvic pain. As such, they suggest that investigation of whether women have intact or injured uterosacral nerves may result in a more meaningful classification of pelvic pain than the presence or absence of endometriosis. We thank Dr. Xia et al for their interest in our article and their insightful comments. We agree that there are many potential causes of chronic pelvic pain, including neurologic, gynecologic, urologic, gastrointestinal, and musculoskeletal sources. Although our knowledge regarding chronic pelvic pain is far from complete, there is increasing evidence to suggest that both the central and peripheral nervous systems play a role in the initiation and maintenance of chronic pelvic pain. 1, 2 The presence of nociceptive Ad and C fiber nerves infiltrating endometriotic lesions was reported in women and rat models more than 10 years ago. 3, 4 More recently, the eutopic endometrium of women afflicted with endometriosis and other causes of chronic pelvic pain, including adenomyosis and leiomyomas, was found to be imbued with significantly denser nerve networks than pain-free control patients. This phenomenon is therefore reflective of a chronic pain state and not limited to just those with biopsy-proven endometriosis.
5 Studies investigating markers of central pain amplification among women with chronic pelvic pain also show independence from the presence or absence of peripheral pathology. For example,
